Adimmune Corporation (TPE:4142)

Taiwan · Delayed Price · Currency is TWD

17.80

-0.15 (-0.84%)

May 8, 2026, 1:30 PM CST

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Adimmune Corporation	1.40B	1.54B	1.77B	2.18B	1.71B
Adimmune Corporation Growth	-8.98%	-13.03%	-18.95%	27.92%	-
Enimmune Corporation	48.20M	39.92M	43.49M	188.42M	109.82M
Enimmune Corporation Growth	20.74%	-8.23%	-76.92%	71.56%	-
Revenue from Internal Divisions	-46.82M	-21.16M	-27.03M	-119.03M	-22.00M
Total	1.40B	1.56B	1.79B	2.25B	1.79B
Total Growth	-9.99%	-12.78%	-20.72%	25.52%	-4.03%

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Taiwan	782.61M	760.25M	842.44M	959.02M	961.50M
Taiwan Growth	2.94%	-9.76%	-12.16%	-0.26%	-25.58%
USA	415.54M	376.93M	326.82M	345.66M	456.18M
USA Growth	10.24%	15.33%	-5.45%	-24.23%	-8.07%
China	123.82M	349.03M	477.56M	632.10M	183.88M
China Growth	-64.52%	-26.91%	-24.45%	243.76%	483.13%
Other	79.53M	70.78M	138.28M	314.84M	192.21M
Other Growth	12.38%	-48.82%	-56.08%	63.80%	289.45%
Total	1.40B	1.56B	1.79B	2.25B	1.79B
Total Growth	-9.99%	-12.78%	-20.72%	25.52%	-4.03%

Source: S&P Global Market Intelligence.